Skip to main content
. 2021 Feb 22;26(5):362–e724. doi: 10.1002/onco.13689

Table 1.

Response rates

Response Assessment (n = 42) % patientsa (95% CI)
Overall response rate 1 2.4 (0.01–0.13)
Clinical benefit rate 23 54.8 (0.39–0.70)
Best response
Complete response 0 0
Partial response 1 2.4
Stable disease 22 52.4
Progressive disease 14 33.3
Could not be evaluatedb 5 11.9
a

Percentages may not total 100 because of rounding.

b

Response not evaluable due to patients prematurely stopping treatment or not receiving second scan.

Abbreviation: CI, confidence interval.